MedValue in the news

Model about the added value of prostate cancer test in the United States published in prominent journal - August 1, 2018

https://mdxhealth.com/press-release/mdxhealth-selectmdx-study-demonstrates-cost-effectiveness-us-healthcare-system

 

 

WS van Berlo

MedValue is joining forces with Van Berlo with an 'Early Proposition Assessment - Workshop'!

Together with Van Berlo, MedValue has designed a workshop to support companies early in their development process with sharpening their value proposition.

During this workshop we will focus on three aspects: the added value for the user, the medical added value and the economic added value.

The first try-out with the entrepreneurs from Momo Medical was a success! Soon the workshop will be available to everyone. Are you already interested? Feel free to contact us!

 

EXCITE International Webinar: Invitation for Netherlands medical technology companies - April, 25 7.30 PM (Dutch time)

New Study Shows MDxHealth's SelectMDx Test is Cost-Effective for Biopsy Selection - April 10, 2017

Radboudumc valorisatie policy 'from idea to spin-off' (Dutch text) - December 2016

Medical technology - Supervising medical innovation in early stage (Dutch text) - August 2016

Role MedValue, controling digital innovations in healthcare (Dutch text) - July 2016 

Campagne 'Innovatie in de zorg' Financieel Dagblad - March 2016

Does scientific research on healthcare innovations take too long?

Medical innovations do not always find their way to the patient

The world of starting and innovating

Care funders & cooperation MedValue

REshape & StartupDelta to MaRS

Radboud REshape & Innovation Center

 
Powered by Radboudumc